특발성 여성형 유방증에서 타목시펜을 이용한 내과적 치료
Medical Treatment for Idiopathic Gynecomastia with Tamoxifen
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: Gynecomastia is a common condition caused by various factors and characterized by the overdevelopment of the male breast glandular tissue. It can cause pain and discomfort, which may require treatment. This study aimed to evaluate the efficacy of tamoxifen in the treatment of idiopathic gynecomastia. Methods: We retrospectively analyzed the medical records of 101 patients who underwent medical treatment for idiopathic gynecomastia using tamoxifen from January 2005 to December 2018. We examined the clinical characteristics that affected resolution and recurrence. Results: The overall resolution rate of gynecomastia among the patients treated with tamoxifen was 89.1%, and the overall recurrence rate was 15.6%. Large size at diagnosis and longer duration of symptoms were significantly different between patients who experienced resolution and those who did not (p=0.017 and p=0.019, respectively). The dosage of tamoxifen did not affect the resolution rate (p=0.609). None of the clinical characteristics were significantly different between patients who experienced recurrence and those who did not. Conclusion: Our study showed that tamoxifen may be an effective treatment for idiopathic gynecomastia.
Abstract
Purpose: Gynecomastia is a common condition caused by various factors and characterized by the overdevelopment of the male breast glandular tissue. It can cause pain and discomfort, which may require treatment. This study aimed to evaluate the efficacy of tamoxifen in the treatment of idiopathic gynecomastia. Methods: We retrospectively analyzed the medical records of 101 patients who underwent medical treatment for idiopathic gynecomastia using tamoxifen from January 2005 to December 2018. We examined the clinical characteristics that affected resolution and recurrence. Results: The overall resolution rate of gynecomastia among the patients treated with tamoxifen was 89.1%, and the overall recurrence rate was 15.6%. Large size at diagnosis and longer duration of symptoms were significantly different between patients who experienced resolution and those who did not (p=0.017 and p=0.019, respectively). The dosage of tamoxifen did not affect the resolution rate (p=0.609). None of the clinical characteristics were significantly different between patients who experienced recurrence and those who did not. Conclusion: Our study showed that tamoxifen may be an effective treatment for idiopathic gynecomastia.
참고문헌 (18)
- Nuttall FQ, "Gynecomastia as a physical finding in normal men", J Clin Endocrinol Metab, 48, pp.338~340 (1979)
- Carlson HE, "Gynecomastia", N Engl J Med, 303, pp.795~799 (1980)
- Marthur R, "Gynecomastia : pathomechanisms and treatment strategies", Horm Res Paediatr, 48, pp.95~102 (1997)
- Jefferys DB, "Painful gynaecomastia treated with tamoxifen", Br Med J, 1, pp.1119~1120 (1979)
- Braunstein GD, "Gynecomastia", N Engl J Med, 328, pp.490~495 (1993)
- Barros AC, "Gynecomastia : physiopathology, evaluation and treatment", Sao Paulo Med J, 130, pp.187~197 (2012)
- Carlson HE, "Approach to the patient with gynecomastia", J Clin Endocrinol Metab, 96, pp.15~21 (2011)
- Thompson DF, "Drug-induced gynecomastia", Pharmacotherapy, 13, pp.37~45 (1993)
- Johnson RE, "Gynecomastia evaluation and current treatment options", Ther Clin Risk Manag, 7, pp.145~148 (2011)
- Johnson RE, "Gynecomastia : pathophysiology, evaluation, and management", Mayo Clin Proc, 84, pp.1010~1015 (2009)
- James R, "The efficacy of tamoxifen in the treatment of primary gynecomastia : an observational study of tamoxifen versus observation alone", Breast J, 18, pp.620~621 (2012)
- Tashkandi M, "The surgical management of high-grade gynecomastia", Ann Plast Surg, 53, pp.17~20 (2004)
- Rahmani S, "Overview of gynecomastia in the modern era and the leeds gynaecomastia Investigation algorithm", Breast J, 17, pp.246~255 (2011)
- Parker LN, "Treatment of gynecomastia with tamoxifen : a double-blind crossover study", Metabolism, 35, pp.705~708 (1986)
- Khan HN, "Management of physiological gynaecomastia with tamoxifen", Breast, 13, pp.61~65 (2004)
- Perdona S, "Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer : a randomised controlled trial", Lancet Oncol, 6, pp.295~300 (2005)
- Ting ACW, "Comparison of tamoxifen with danazol in the management of idiopathic gynecomastia", Am Surg, 66, pp.38~40 (2000)
- Plourde PV, "Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia : a randomized, double-blind, placebo-controlled trial", J Clin Endocrinol Metab, 89, pp.4428~4433 (2004)